Key facts
- Rollgevity’s last known valuation is $6.0M (Jan 2026).
- It has raised $50K; the latest was Angel (individual) ($50K) in Jan 2026.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Rollgevity
- ·The full record, as it builds
Funding rounds
No funding rounds for Rollgevity are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rollgevity
Developer of a wellness technology company designed to provide an automated fascia and lymphatic care system. The company offers an intelligent roller that integrates fascia release, lymphatic drainage, and circulation enhancement, adapts to personal goals, tracks progress, and syncs with wearables, enabling individuals focused on daily self-care to modernize self-massage into an effortless, personalized, and feel-good experience.
- Sector
- Healthcare
- HQ
- Sacramento, CA, United States
- Founded
- 2025
- Employees
- 2
- Website
- rollgevity.com/
- Ownership
- Privately Held (backing)
Rollgevity doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rollgevity shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rollgevity in its N-PORT filings yet. We sweep new filings monthly.